ImmPACT Bio USA Funding: $129M Raised, Series B (2022)
ImmPACT Bio USA is based in Camarillo, CA. It has raised $129M in total funding. Latest round: Series B.
ImmPACT Bio USA funding overview
ImmPACT Bio USA is based in Camarillo, CA. ImmPACT Bio USA has raised $129M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for ImmPACT Bio USA runs through 2022; nothing later has been disclosed. Investors on record include venBio Partners, Foresite Capital, Decheng Capital, Surveyor Capital. 4 distinct backers are named across the disclosed rounds.
ImmPACT Bio USA at a glance
Total raised
$129M
Latest round
Series B
Latest round date
January 2022
Headquarters
Camarillo, CA
Notable investors
venBio Partners, Foresite Capital, Decheng Capital, Surveyor Capital
Frequently asked about ImmPACT Bio USA funding
How much has ImmPACT Bio USA raised?
ImmPACT Bio USA has raised $129M in total disclosed funding across the rounds on record.
Who has invested in ImmPACT Bio USA?
venBio Partners, Foresite Capital, Decheng Capital, Surveyor Capital are named among the investors backing ImmPACT Bio USA.
What was the latest ImmPACT Bio USA funding round?
The most recent disclosed round is a Series B, announced in January 2022.
Where is ImmPACT Bio USA based?
ImmPACT Bio USA is based in Camarillo, CA.
When did ImmPACT Bio USA last raise?
The last disclosed ImmPACT Bio USA round closed in January 2022 at Series B.
ImmPACT Bio USA totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Camarillo below to benchmark round size and investor mix.
